References

Abken, H., A. Hombach, C. Heuser, K. Kronfeld and B. Seliger, 2002. Tuning tumor-specific T-cell activation: A matter of costimulation? Trends. Immunol., 23: 240-245.
CrossRef  |  Direct Link  |  

Aerts, I., L. Lumbroso-Le Rouic, M. Gauthier-Villars, H. Brisse, F. Doz and L. Desjardins, 2006. Retinoblastoma. Orphanet J. Rare Dis., Vol. 1. 10.1186/1750-1172-1-31

Antoneli, C.B., K.C. Ribeiro, F. Steinhorst, P.E. Novaes and M.M. Chojniak et al., 2006. Treatment of retinoblastoma patients with chemoreduction plus local therapy: Experience of the AC Camargo Hospital, Brazil. J. Pediatr. Hematol. Oncol., 28: 342-345.

Azuma, T., S. Yao, G. Zhu, A. S. Flies, S.J. Flies and L. Chen, 2008. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood, 111: 3635-3643.
CrossRef  |  Direct Link  |  

Chang, L. and M. Karin, 2001. Mammalian MAP kinase signalling cascades. Nature, 410: 37-40.
PubMed  |  Direct Link  |  

Chen, L., 2004. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol., 4: 336-347.
CrossRef  |  PubMed  |  Direct Link  |  

Chintagumpala, M., P. Chevez-Barrios, E.A. Paysse, S.E. Plon and R. Hurwitz, 2007. Retinoblastoma: Review of current management. Oncologist, 12: 1237-1246.
PubMed  |  Direct Link  |  

Cohen, P.A., L. Peng, J. Kjaergaard, G.E. Plautz and J.H. Finke et al., 2001. T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance. Crit. Rev. Immunol., 21: 215-248.
Direct Link  |  

Curiel, T.J., S. Wei, H. Dong, X. Alvarez and P. Cheng et al., 2003. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature. Med., 9: 562-567.
Direct Link  |  

Dong, H. and L. Chen, 2003. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med., 81: 281-287.
PubMed  |  Direct Link  |  

Dong, H. and X. Chen, 2006. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell. Molecul. Immunol., 3: 179-187.
Direct Link  |  

Dong, H., G. Zhu, K. Tamada and L. Chen, 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med., 5: 1365-1369.
CrossRef  |  Direct Link  |  

Dong, H., S.E. Strome, D.R. Salomao, H. Tamura and F. Hirano et al., 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nat. Med., 8: 793-800.
Direct Link  |  

Dunn, G.P., A.T. Bruce, H. Ikeda, L.J. Old and R.D. Schreiber, 2002. Cancer immunoediting: From immunosurveillance to tumor escape. Nat. Immunol., 3: 991-998.
Direct Link  |  

Hanson, H.L., D.L. Donermeyer, H. Ikeda, J.M. White and V. Shankaran et al., 2000. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity, 13: 265-276.
Direct Link  |  

Jantzer, P. and D.J. Schendel, 1998. Human renal cell carcinoma antigen-specific CTLs: Antigen-driven selection and long-term persistence in vivo. Cancer Res., 58: 3078-3086.
Direct Link  |  

Khong, H.T. and N.P. Restifo, 2002. Natural selection of tumor variants in the generation of tumor escape phenotypes. Nature Immunol., 3: 999-1005.
CrossRef  |  Direct Link  |  

Lee, P.P., C. Yee, P.A. Savage, L. Fong and D. Brockstedt et al., 1999. Characterization of circulating T cells specific for tumour-associated antigens in melanoma patients. Nat. Med., 5: 677-685.
Direct Link  |  

Lee, S.J., B.C. Jang, S.W. Lee, Y.I. Yang and S.I. Suh et al., 2006. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett., 580: 755-762.
Direct Link  |  

Liu, J., A. Hamrouni, D. Wolowiec, V. Coiteux and K. Kuliczkowski et al., 2007. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood, 110: 296-304.
Direct Link  |  

Lopez-Fraga, M., T. Martinez and A. Jimenez, 2009. RNA interference technologies and therapeutics: From basic research to products. Bio. Drugs, 23: 305-332.
CrossRef  |  Direct Link  |  

Muhlbauer, M., M. Fleck, C. Schutz, T. Weiss and M. Froh et al., 2006. PD-L1 is induced in hepatocytes by viral infection and by interferon α and γ and mediates T cell apoptosis. J. Hepatol., 45: 520-528.
CrossRef  |  Direct Link  |  

Parsa, A.T., J.S. Waldron, A. Panner, C.A. Crane and I.F. Parney et al., 2007. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat. Med., 13: 84-88.
Direct Link  |  

Rameshwar, P., 2008. IFNgamma and B7-H1 in the immunology of mesenchymal stem cells. Cell Res., 18: 805-806.
CrossRef  |  Direct Link  |  

Smyth, M.J., D.I. Godfrey and J.A. Trapani, 2001. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol., 2: 293-299.
Direct Link  |  

Thompson, R.H., E.D. Kwon and J.P. Allison, 2009. Inhibitors of B7-CD28 costimulation in urologic malignancies. Immunotherapy, 1: 129-139.
CrossRef  |  Direct Link  |  

Usui, Y., Y. Okunuki, T. Hattori, M. Takeuchi and T. Kezuka et al., 2006. Expression of costimulatory molecules on human retinoblastoma cells Y-79: Functional expression of CD40 and B7H1. Investig. Ophthalmol. Visual. Sci., 47: 4607-4613.
PubMed  |  Direct Link  |  

Yamamoto, R., M. Nishikori, M. Tashima, T. Sakai and T. Ichinohe et al., 2009. B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma. Cancer Sci., 100: 2093-2100.
CrossRef  |  Direct Link  |